Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
October 11, 2023 at 12:29 PM EDT
The drug candidate showed clinical superiority as a first-line treatment for unresectable or metastatic hepatocellular carcinoma, a common type of liver cancer.
